🚀 VC round data is live in beta, check it out!
Abera Bioscience Valuation Multiples
Discover revenue and EBITDA valuation multiples for Abera Bioscience and similar public comparables like Biogened, Jupiter Neurosciences, NextCell Pharma, NFL Biosciences and more.
Abera Bioscience Overview
About Abera Bioscience
Abera Bioscience AB is a platform and vaccine development company based on research in the medical, molecular, and microbiological fields. The company's mission is to develop vaccine candidates based on its novel vaccine delivery platform to late pre-clinical or early clinical phase.
Founded
2012
HQ
Employees
6
Website
Sectors
Financials (FY)
EV
$13M
Abera Bioscience Financials
Abera Bioscience reported last fiscal year revenue of — and negative EBITDA of ($1M).
In the same fiscal year, Abera Bioscience generated ($1M) in EBITDA losses and had net loss of ($1M).
Abera Bioscience P&L
In the most recent fiscal year, Abera Bioscience reported revenue of — and EBITDA of ($1M).
Abera Bioscience expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| EBITDA | — | XXX | ($1M) | XXX | XXX | XXX |
| Net Profit | — | XXX | ($1M) | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Abera Bioscience Stock Performance
Abera Bioscience has current market cap of $16M, and enterprise value of $13M.
Market Cap Evolution
Abera Bioscience's stock price is $0.76.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $13M | $16M | -0.5% | XXX | XXX | XXX | $-0.06 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialAbera Bioscience Valuation Multiples
Abera Bioscience trades at (11.7x) EV/EBITDA.
Abera Bioscience Financial Valuation Multiples
As of April 19, 2026, Abera Bioscience has market cap of $16M and EV of $13M.
Equity research analysts estimate Abera Bioscience's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Abera Bioscience has a P/E ratio of (13.7x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $16M | XXX | $16M | XXX | XXX | XXX |
| EV (current) | $13M | XXX | $13M | XXX | XXX | XXX |
| EV/EBITDA | — | XXX | (11.7x) | XXX | XXX | XXX |
| EV/EBIT | — | XXX | (11.3x) | XXX | XXX | XXX |
| P/E | — | XXX | (13.7x) | XXX | XXX | XXX |
| EV/FCF | — | XXX | (32.6x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Abera Bioscience Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Abera Bioscience Margins & Growth Rates
Abera Bioscience's revenue in the last fiscal year grew by —.
Abera Bioscience's revenue per employee in the last FY averaged $0.0M, while opex per employee averaged $0.2M for the same period.
Abera Bioscience Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| EBITDA Growth | — | XXX | 890% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.0M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.2M | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Abera Bioscience Public Comps
See public comps and valuation multiples for other Biopharmaceuticals comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Abera Bioscience | XXX | XXX | XXX | XXX | XXX | XXX |
| Biogened | XXX | XXX | XXX | XXX | XXX | XXX |
| Jupiter Neurosciences | XXX | XXX | XXX | XXX | XXX | XXX |
| NextCell Pharma | XXX | XXX | XXX | XXX | XXX | XXX |
| NFL Biosciences | XXX | XXX | XXX | XXX | XXX | XXX |
| Genenta Science | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Abera Bioscience M&A Activity
Abera Bioscience acquired XXX companies to date.
Last acquisition by Abera Bioscience was on XXXXXXXX, XXXXX. Abera Bioscience acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Abera Bioscience
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialAbera Bioscience Investment Activity
Abera Bioscience invested in XXX companies to date.
Abera Bioscience made its latest investment on XXXXXXXX, XXXXX. Abera Bioscience invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Abera Bioscience
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Abera Bioscience
| When was Abera Bioscience founded? | Abera Bioscience was founded in 2012. |
| Where is Abera Bioscience headquartered? | Abera Bioscience is headquartered in Sweden. |
| How many employees does Abera Bioscience have? | As of today, Abera Bioscience has over 6 employees. |
| Is Abera Bioscience publicly listed? | Yes, Abera Bioscience is a public company listed on Nasdaq Stockholm. |
| What is the stock symbol of Abera Bioscience? | Abera Bioscience trades under ABERA ticker. |
| When did Abera Bioscience go public? | Abera Bioscience went public in 2021. |
| Who are competitors of Abera Bioscience? | Abera Bioscience main competitors are Biogened, Jupiter Neurosciences, NextCell Pharma, NFL Biosciences. |
| What is the current market cap of Abera Bioscience? | Abera Bioscience's current market cap is $16M. |
| Is Abera Bioscience profitable? | No, Abera Bioscience is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.